194 related articles for article (PubMed ID: 35394031)
1. Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy.
Yang C; Li J; Deng Z; Luo S; Liu J; Fang W; Liu F; Liu T; Zhang X; Zhang Y; Meng Z; Zhang S; Luo J; Liu C; Yang D; Liu L; Sukhova GK; Sadybekov A; Katritch V; Libby P; Wang J; Guo J; Shi GP
Cardiovasc Res; 2023 Mar; 119(1):195-212. PubMed ID: 35394031
[TBL] [Abstract][Full Text] [Related]
2. Eosinophils Protect Mice From Angiotensin-II Perfusion-Induced Abdominal Aortic Aneurysm.
Liu CL; Liu X; Zhang Y; Liu J; Yang C; Luo S; Liu T; Wang Y; Lindholt JS; Diederichsen A; Rasmussen LM; Dahl M; Sukhova GK; Lu G; Upchurch GR; Libby P; Guo J; Zhang J; Shi GP
Circ Res; 2021 Jan; 128(2):188-202. PubMed ID: 33153394
[TBL] [Abstract][Full Text] [Related]
3. Cationic proteins from eosinophils bind bone morphogenetic protein receptors promoting vascular calcification and atherogenesis.
Meng Z; Zhang S; Li W; Wang Y; Wang M; Liu X; Liu CL; Liao S; Liu T; Yang C; Lindholt JS; Rasmussen LM; Obel LM; Stubbe J; Diederichsen AC; Sun Y; Chen Y; Yu PB; Libby P; Shi GP; Guo J
Eur Heart J; 2023 Aug; 44(29):2763-2783. PubMed ID: 37279475
[TBL] [Abstract][Full Text] [Related]
4. Eosinophils improve cardiac function after myocardial infarction.
Liu J; Yang C; Liu T; Deng Z; Fang W; Zhang X; Li J; Huang Q; Liu C; Wang Y; Yang D; Sukhova GK; Lindholt JS; Diederichsen A; Rasmussen LM; Li D; Newton G; Luscinskas FW; Liu L; Libby P; Wang J; Guo J; Shi GP
Nat Commun; 2020 Dec; 11(1):6396. PubMed ID: 33328477
[TBL] [Abstract][Full Text] [Related]
5. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
[TBL] [Abstract][Full Text] [Related]
6. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
[TBL] [Abstract][Full Text] [Related]
7. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
8. Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis.
Sari N; Katanasaka Y; Sugiyama Y; Sunagawa Y; Miyazaki Y; Funamoto M; Shimizu S; Shimizu K; Murakami A; Mori K; Wada H; Hasegawa K; Morimoto T
Phytomedicine; 2021 Nov; 92():153744. PubMed ID: 34563985
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
[TBL] [Abstract][Full Text] [Related]
10. Role of type 2A phosphatase regulatory subunit B56α in regulating cardiac responses to β-adrenergic stimulation in vivo.
Puhl SL; Weeks KL; Güran A; Ranieri A; Boknik P; Kirchhefer U; Müller FU; Avkiran M
Cardiovasc Res; 2019 Mar; 115(3):519-529. PubMed ID: 30203051
[TBL] [Abstract][Full Text] [Related]
11. Chronic Pressure Overload Induces Cardiac Hypertrophy and Fibrosis via Increases in SGLT1 and IL-18 Gene Expression in Mice.
Matsushita N; Ishida N; Ibi M; Saito M; Sanbe A; Shimojo H; Suzuki S; Koepsell H; Takeishi Y; Morino Y; Taira E; Sawa Y; Hirose M
Int Heart J; 2018 Sep; 59(5):1123-1133. PubMed ID: 30101852
[TBL] [Abstract][Full Text] [Related]
12. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
[TBL] [Abstract][Full Text] [Related]
15. Group 2 innate lymphoid cells protect mouse heart from myocardial infarction injury via interleukin 5, eosinophils, and dendritic cells.
Liu T; Meng Z; Liu J; Li J; Zhang Y; Deng Z; Luo S; Wang M; Huang Q; Zhang S; Fendt P; Devouassoux J; Li D; McKenzie ANJ; Nahrendorf M; Libby P; Guo J; Shi GP
Cardiovasc Res; 2023 May; 119(4):1046-1061. PubMed ID: 36063432
[TBL] [Abstract][Full Text] [Related]
16. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload.
von Lueder TG; Gravning J; How OJ; Vinge LE; Ahmed MS; Krobert KA; Levy FO; Larsen TS; Smiseth OA; Aasum E; Attramadal H
Am J Physiol Heart Circ Physiol; 2012 Jul; 303(1):H66-74. PubMed ID: 22542621
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
[TBL] [Abstract][Full Text] [Related]
19. Cardiac fibroblast-specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism.
Bageghni SA; Hemmings KE; Zava N; Denton CP; Porter KE; Ainscough JFX; Drinkhill MJ; Turner NA
FASEB J; 2018 Sep; 32(9):4941-4954. PubMed ID: 29601781
[TBL] [Abstract][Full Text] [Related]
20. Intracardiac basic fibroblast growth factor and transforming growth factor-beta 1 mRNA and their proteins expression level in patients with pressure or volume-overload right or left ventricular hypertrophy.
He ZY; Feng B; Yang SL; Luo HL
Acta Cardiol; 2005 Feb; 60(1):21-5. PubMed ID: 15779847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
